Fluorescent Dyes < Fluorine Radioisotopes < Fluorodeoxyglucose F18

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]

Ident.	Authors (with country if any)	Title
000C01 (2011)	W R Wayne Martin	Fuming over Parkinson disease: are welders at risk?
001024 (2007)	A Jon Stoessl [Canada]	Positron emission tomography in premotor Parkinson's disease.
001201 (2005)	John R. Adams [Canada] ; Hinke Van Netten ; Michael Schulzer ; Edwin Mak ; Jessamyn Mckenzie ; Audrey Strongosky ; Vesna Sossi ; Thomas J. Ruth ; Chong S. Lee ; Matthew Farrer ; Thomas Gasser ; Ryan J. Uitti ; Donald B. Calne ; Zbigniew K. Wszolek ; A Jon Stoessl	PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
001325 (2004)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández ; James E. Holden ; Michael Schulzer ; Thomas J. Ruth ; Jon Stoessl	Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms.
001342 (2003)	Raúl De La Fuente-Fernández [Canada] ; Sarah Furtado ; Mark Guttman ; Yoshiaki Furukawa ; Chong S. Lee ; Donald B. Calne ; Thomas J. Ruth ; A Jon Stoessl	VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
001357 (2003)	Doris J. Doudet [Canada] ; James E. Holden	Raclopride studies of dopamine release: dependence on presynaptic integrity.
001397 (2003)	V. Sossi [Canada] ; J E Holden ; R. De La Fuente-Fernandez ; T J Ruth ; A J Stoessl	Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki.
001418 (2003)	Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim ; Vesna Sossi ; Michael J. Adam ; Thomas J. Ruth ; Donald B. Calne ; A Jon Stoessl ; Chong S. Lee	Age and severity of nigrostriatal damage at onset of Parkinson's disease.
001457 (2002)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández ; James E. Holden ; Doris J. Doudet ; Jess Mckenzie ; A J Stoessl ; T J Ruth	Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
001578 (2000)	C S Lee [Canada] ; A. Samii ; V. Sossi ; T J Ruth ; M. Schulzer ; J E Holden ; J. Wudel ; P K Pal ; R. De La Fuente-Fernandez ; D B Calne ; A J Stoessl	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
001586 (2000)	R. De La Fuente-Fernández [Canada] ; P K Pal ; F J Vingerhoets ; A. Kishore ; M. Schulzer ; E K Mak ; T J Ruth ; B J Snow ; D B Calne ; A J Stoessl	Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
001588 (2000)	I. Mendez [Canada] ; A. Dagher ; M. Hong ; A. Hebb ; P. Gaudet ; A. Law ; S. Weerasinghe ; D. King ; J. Desrosiers ; S. Darvesh ; T. Acorn ; H. Robertson	Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations.
001769 (1997)	D B Calne [Canada] ; R. De La Fuente-Fernández ; A. Kishore	Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.
001783 (1996)	F J Vingerhoets [Canada] ; M. Schulzer ; T J Ruth ; J E Holden ; B J Snow	Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease.
001794 (1996)	L. Wahl [Canada] ; C. Nahmias	Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
001834 (1995)	H. Kuwabara [Canada] ; P. Cumming ; Y. Yasuhara ; G C Léger ; M. Guttman ; M. Diksic ; A C Evans ; A. Gjedde	Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
001861 (1995)	C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E S Garnett	A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
001909 (1994)	W R Martin [Canada] ; J S Perlmutter	Assessment of fetal tissue transplantation in Parkinson's disease: does PET play a role?
001922 (1993)	B J Snow [Canada] ; T G Nygaard ; H. Takahashi ; D B Calne	Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
001923 (1993)	P. Cumming [Canada] ; G C Léger ; H. Kuwabara ; A. Gjedde	Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
001953 (1993)	M. Guttman [Canada] ; G. Léger ; A. Reches ; A. Evans ; H. Kuwabara ; J M Cedarbaum ; A. Gjedde	Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Fluorine Radioisotopes" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Fluorine Radioisotopes" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Fluorine Radioisotopes
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022